21 Jun 2018

MOST VENOUS DISEASE CAN BE CLASSIFIED AS COSMETIC

      By Ronald Bush, MD, FACS In 1992, I left a busy practice of thoracic and vascular surgery and began the in-office treatment of varicose veins. At that time, high ligation and stripping using tumescent with ultra sound guided assistance was our treatment of choice for saphenous insufficiency.

0
13 Jun 2018

CASE STUDY: MANAGING PERSISTENT SWELLING AFTER ENDOVENOUS ABLATION

  By Tim Crawlield I have practiced phleboloby for six years and I learned early in my career that patients with swelling in the lower extremities — swelling that cannot be contained by elastic graduated compression stockings — do not benefit from endovenous ablations. My general rule of thumb is

0
13 Jun 2018

ACP OPENS REGISTRATION FOR 32ND ANNUAL CONGRESS IN NASHVILLEW

  Early registration for the 32nd Annual Congress Nov.8-11 at the Gaylord Opryland Hotel and Convention Center in Nashville is now open. To register, see acpcongress.org/application-form-1. Dr. Stephen Daugherty and the American College of Phlebology (APC) invite all physicians to “Raise your Voice” as the New Horizon at the 32nd

0
13 Jun 2018

ACP CALL FOR PAPERS FOR 2018  ANNUAL CONGRESS IS JUNE 20

The American College of Phlebology (ACP) is now accepting abstracts to be presented at the 2018 ACP Annual Congress Nov. 8-11 in Nashville.  Deadline is June 20 All seasoned practicing clinicians, research scientists, young investigators, physician extenders, nurses, lymphedema therapists, ultrasound technicians, and medical students are encouraged to submit original

0
13 Jun 2018

2018 RESEARCH SUMMIT: WORK BEGINS TO ANALYZE DATA IN RAPIDLY EXPANDING ACP PRO VENOUS REGISTRY

By Vanessa Salvia Contributing Editor Anticipation was high for many members of the phlebology community going into an April 21 closed-door research summit held alongside the International Vein Congress in Miami, convened to discuss how to make the most of the American College of Phlebology’s Patient Recorded Outcome Venous Registry,

0
07 Jun 2018

OPTALYSE PE: BTG RESULTS REINFORCE SAFETY, EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE

BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to

0
29 May 2018

INTACT VASCULAR SPONSORS SYMPOSIUM ON POST-ANGIOPLASTY DISSECTIONS MAY 31

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced May 29 the schedule of key presentations that will be featured during a symposium sponsored together with Philips at the 19th Annual New Cardiovascular Horizons (NCVH) Conference  in New Orleans on May 31. Post-Percutaneous Transluminal Angioplasty (“PTA”)

0
14 May 2018

THANK YOU! THE HEROISM OF NURSES IN OUR PRACTICES AND IN OUR LIVES SHOULD BE A DAILY CELEBRATION

  National Nurses Day was May 6 and National Nurses Week ends May 12, which is Florence Nightingale’s birthday. Nurse Nightingale, who came to prominence while serving as a British manager and trainer of nurses during the Crimean War, is the founder of modern nursing and it’s appropriate that on

0
11 May 2018

JOHN CHUBACK, MD, FACS, JOINS VEIN THERAPY NEWS EDITORIAL ADVISORY BOARD

John Chuback, MD, FACS, chief medical officer at Chuback Medical Group in Paramus, N.J., has joined the Vein Therapy News (VTN) Editorial Advisory Board. Dr. Chuback is involved in teaching, entrepreneurship, writing and philanthropy. He is also co-founder of BiosupportMD and Chuback Education. He is an author of numerous articles

0
11 May 2018

BOVIE MEDICAL ADDS PLASTIC SURGEON TO BOARD

Diane I. Duncan, MD, FACS has been named to the Bovie Medical Corp. Medical Advisory Board, a maker of medical devices and supplies and the developer of J-Plasma, a patented surgical product marketed and sold under the Renuvion Cosmetic Technology brand in the cosmetic surgery market, “Dr. Duncan, who is

0